Alembic Pharmaceuticals announced after trading hours yesterday, 12 February 2019, that its wholly-owned step-down subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Tablets USP, 54 ...read more